<doc>
  <docmeta id="113s2783is">
    <bill congress="113" type="s" number="2783" version="is"/>
    <revision size="16749" annotations="0" status="complete" id="6" commit-time="2014-10-15T19:01:28Z" committer="mbohmer" doc="113s2783is/6.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" public-private="public">
  <metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 S2783 IS: VBID for Better Care Act of 2014</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. Senate</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-09-10</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code>
    <congress>113th CONGRESS</congress>
    <session>2d Session</session>
    <legis-num>S. 2783</legis-num>
    <current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
    <action>
      <action-date date="20140910">September 10, 2014</action-date>
      <action-desc>
        <sponsor name-id="S303">Mr. Thune</sponsor> (for himself and <cosponsor name-id="S284">Ms. Stabenow</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSFI00">Committee on Finance</committee-name>
      </action-desc>
    </action>
    <legis-type>A BILL</legis-type>
    <official-title>To establish a demonstration program requiring the utilization of Value-Based Insurance Design to
			 demonstrate that reducing the copayments or coinsurance charged to
			 Medicare beneficiaries for selected high-value prescription medications
			 and clinical services can increase their utilization and ultimately
			 improve clinical outcomes and lower health care expenditures.</official-title>
  </form>
  <legis-body id="H9EBCCA69EE264BA7B386CD2CA21C3566" style="OLC">
    <section id="H3390C765DB9C47519E1706CBB0A194E2" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <quote>
          <short-title>
            <cato:entity-ref proposed="true" value="Value Based Insurance Design for Better Care Act of 2014" entity-type="act">Value Based Insurance Design for Better Care Act of 2014</cato:entity-ref>
          </short-title>
        </quote> or the <quote>
          <cato:entity-ref proposed="true" value="VBID for Better Care Act of 2014" entity-type="act">VBID for Better Care Act of 2014</cato:entity-ref>
        </quote>.</cato:entity>
      </text>
    </section>
    <section id="H8818117DC65C43CCB0D1298777366CBC">
      <enum>2.</enum>
      <header>Findings</header>
      <text display-inline="no-display-inline">
        <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="0001" entity-type="federal-body">Congress</cato:entity-ref> makes the following findings:</text>
      <paragraph id="H32F5AC3177064215A9AF3766441F22BB">
        <enum>(1)</enum>
        <text>A growing body of evidence demonstrates that increases in patient-level financial barriers
			 (including deductibles, copayments, and coinsurance) for high-value
			 medical services (such as prescription medications, clinician visits,
			 diagnostic tests, and procedures) systematically reduce their use. Savings
			 attributable to cost-related decreased utilization of specific services
			 may lead to an increase in total medical expenditures due to increased use
			 of other related clinical services, such as hospitalizations and emergency
			 room visits.</text>
      </paragraph>
      <paragraph id="HB169A136E3D4478D9E099AAAD6C269EC">
        <enum>(2)</enum>
        <text>Empirical research studies demonstrate that reductions in beneficiary out-of-pocket expenses for
			 high-value prescription medications and clinical services can mitigate the
			 adverse health and financial consequences attributable to cost-related
			 decreased utilization of high-value services.</text>
      </paragraph>
      <paragraph id="HF524BD10F07E47EF854EB5F8DDE3A3AC">
        <enum>(3)</enum>
        <text>Financial barriers to prescription medications and clinical services that are deemed to be
			 high value should be reduced or eliminated to increase their use.</text>
      </paragraph>
      <paragraph id="H507BFAB9DF2C415EA8107816CA562B1C">
        <enum>(4)</enum>
        <text>Value-Based Insurance Design is a methodology that adjusts patient out-of-pocket costs for
			 prescription medications and clinical services according to the clinical
			 value—not exclusively the cost. Value-Based Insurance Design is based on
			 the concept of clinical nuance that recognizes—</text>
        <subparagraph id="H91D49DE532494546A1A4F65D39FEA98F">
          <enum>(A)</enum>
          <text>prescription medications and clinical services differ in the clinical benefit provided; and</text>
        </subparagraph>
        <subparagraph id="H92B26DE010144AE88FFD3D15286EB6D7">
          <enum>(B)</enum>
          <text>the clinical benefit derived from a specific prescription medication or clinical service depends on
			 the clinical situation, the provider, and where the care is delivered.</text>
        </subparagraph>
      </paragraph>
      <paragraph id="HCD72611FBC924703AECB72966C354552">
        <enum>(5)</enum>
        <text>The current <quote>one-size-fits-all</quote> copayment or coinsurance design for prescription medications and clinical services provided under
			 the Medicare program does not recognize the well-established value
			 differences in health outcomes produced by various medical interventions.</text>
      </paragraph>
      <paragraph id="HAF2A3089577C4F60A8EAC3312EA29DE0">
        <enum>(6)</enum>
        <text>The establishment by Medicare of copayment and coinsurance requirements using Value-Based Insurance
			 Design methodologies will improve patient-centered health outcomes,
			 enhance personal responsibility, and afford a more efficient use of
			 taxpayer dollars.</text>
      </paragraph>
    </section>
    <section id="H9F1EEA8F59224419B1A6922210510FDB">
      <enum>3.</enum>
      <header>Demonstration program</header>
      <subsection id="H0D60ECC08D674BDF96FB584F8B008017">
        <enum>(a)</enum>
        <header>In general</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary of Health and Human Services</cato:entity-ref> (in this section referred to as the <quote>Secretary</quote>) shall establish a 3-year demonstration program to test the use of value-based insurance design
			 methodologies (as defined in subsection (c)(1)) under eligible Medicare
			 Advantage plans offered by Medicare Advantage organizations under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Social Security Act/t:XVIII/pt:C">part C
			 of title XVIII of the Social Security Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-21">
            <cato:entity-ref value="usc/42/1395w–21/etseq" entity-type="uscode">42 U.S.C. 1395w–21 et seq.</cato:entity-ref>
            </external-xref>)</cato:entity>.</text>
      </subsection>
      <subsection id="H52871106CE7B4B299D6760A37B3AA90D">
        <enum>(b)</enum>
        <header>Demonstration program design</header>
        <paragraph id="H92FA036038724F38B072D26D3A20E088">
          <enum>(1)</enum>
          <header>Selection of MA region and eligible Medicare Advantage plans</header>
          <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall—</text>
          <subparagraph id="HA4740EDDAEEA42D5A3F477E1C3C7C673">
            <enum>(A)</enum>
            <text>select at least two MA regions (as defined in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                <cato:entity-ref value="Social Security Act/s:1858/ss:a/p:2" entity-type="act">section 1858(a)(2) of the Social Security Act</cato:entity-ref> (<cato:entity-ref value="usc/42/1395w–27a/a/2" entity-type="uscode">42
			 U.S.C. 1395w–27a(a)(2)</cato:entity-ref>)</cato:entity>) with respect to which to conduct the
			 demonstration
			 program under this section; and</text>
          </subparagraph>
          <subparagraph id="HC67AAA979A824CEB9AC84F7BC3F777A8">
            <enum>(B)</enum>
            <text>approve eligible Medicare Advantage plans to participate in such demonstration program.</text>
          </subparagraph>
        </paragraph>
        <paragraph id="H713990948D474F42B27704DC34E6A865">
          <enum>(2)</enum>
          <header>Start of demonstration</header>
          <text display-inline="yes-display-inline">The demonstration program shall begin with respect to the first plan year beginning after the date
			 on which at least two eligible Medicare Advantage plans have been approved
			 by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> in at least one MA region selected under paragraph (1).</text>
        </paragraph>
        <paragraph id="H3C413525CB9E40C38AB5D96515A2F14A">
          <enum>(3)</enum>
          <header>Eligible Medicare Advantage plans</header>
          <text display-inline="yes-display-inline">For purposes of this section, the term <term>eligible Medicare Advantage plan</term> means a Medicare Advantage plan under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Social Security Act/t:XVIII/pt:C">part C of title XVIII of the Social Security Act</cato:entity-ref> (<cato:entity-ref value="usc/42/1395w–21/etseq" entity-type="uscode">42 U.S.C.
			 1395w–21 et seq.</cato:entity-ref>)</cato:entity> that meets the following requirements:</text>
          <subparagraph commented="no" id="HE918A41F663B4666BC7C342DF9C601E4">
            <enum>(A)</enum>
            <text>The plan is an MA regional plan (as defined in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                <cato:entity-ref value="Social Security Act/s:1859/ss:b/p:4" entity-type="act">paragraph (4) of section 1859(b) of such Act</cato:entity-ref> (<cato:entity-ref value="usc/42/1395w–28/b" entity-type="uscode">42
			 U.S.C. 1395w–28(b)</cato:entity-ref>)</cato:entity>) or MA local plan (as defined in paragraph (5) of such
			 section) offered in the MA region selected under paragraph (1)(A).</text>
          </subparagraph>
          <subparagraph id="H60C8E0B4E2EE4629AA5BA230B5958BA5">
            <enum>(B)</enum>
            <text>The plan has—</text>
            <clause commented="no" id="HC47F304229184FC3886CCF9693CAABD1">
              <enum>(i)</enum>
              <text>a quality rating under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                  <cato:entity-ref value="Social Security Act/s:1853/ss:n/p:4" entity-type="act">section 1853(n)(4) of such Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-23">
                    <cato:entity-ref value="usc/42/1395w–23/n/4" entity-type="uscode">
                  42 U.S.C. 1395w–23(n)(4)</cato:entity-ref>
                  </external-xref>)</cato:entity> of 4 stars or
			 higher based on the most recent data available for such year;</text>
            </clause>
            <clause commented="no" id="H607D16B02F28497F84CAF2BE1BA052E0">
              <enum>(ii)</enum>
              <text display-inline="yes-display-inline">in the case of a specialized MA plan for special needs individuals, as defined in subsection
			 (b)(6)(A) of <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                  <cato:entity-ref entity-type="act" value="Social Security Act/s:1859/ss:b/p:6/sp:A">section 1859(b)(6)(A) of such Act</cato:entity-ref> (<cato:entity-ref value="usc/42/1395w–28/b/6/A" entity-type="uscode">42 U.S.C.
			 1395w–28(b)(6)(A)</cato:entity-ref>)</cato:entity>, received a multi-year approval by the National
			 Committee for Quality Assurance under subsection (f)(7) of such section;
			 or</text>
            </clause>
            <clause id="H0A37A7228A0F468C8C7955B64B9402F9">
              <enum>(iii)</enum>
              <text display-inline="yes-display-inline">at least 20 percent of the population to whom the plan is offered consists of subsidy eligible
			 individuals (as defined in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                  <cato:entity-ref value="Social Security Act/s:1860D–14/ss:a/p:3/sp:A" entity-type="act">section 1860D–14(a)(3)(A) of the Social
			 Security Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-114">
                    <cato:entity-ref value="usc/42/1395w–114/a/3/A" entity-type="uscode">
                  42 U.S.C. 1395w–114(a)(3)(A)</cato:entity-ref>
                  </external-xref>)</cato:entity>).</text>
            </clause>
          </subparagraph>
        </paragraph>
      </subsection>
      <subsection id="H9103FDCBAD894D9DBBC4E9F13FDD1D9F">
        <enum>(c)</enum>
        <header>Value-Based insurance design methodologies</header>
        <paragraph id="H6A0B0F726E7C4A30A4B28AF2F531710B">
          <enum>(1)</enum>
          <header>Definition</header>
          <text display-inline="yes-display-inline">For purposes of this section, the term <term>value-based insurance design methodology</term> means a methodology for identifying specific prescription medications, and clinical services that
			 are reimbursable under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/t:XVIII">title XVIII of the Social Security Act</cato:entity-ref>, for which
			 copayments, coinsurance, or both should be reduced or eliminated because
			 of the high value and effectiveness of such medications and services for
			 specific chronic clinical conditions (as approved by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>).</text>
        </paragraph>
        <paragraph id="HBF08B845B02E42B1BAD2FBEA2BFF84C4">
          <enum>(2)</enum>
          <header>Use of methodologies to reduce copayments and coinsurance</header>
          <text display-inline="yes-display-inline">A Medicare Advantage organization offering an eligible Medicare Advantage plan selected to
			 participate under the demonstration program, for each plan year for which
			 the plan is so selected and using value-based insurance design
			 methodologies—</text>
          <subparagraph id="H532D7E37FEA64E7FAACB2242D72E4055">
            <enum>(A)</enum>
            <text display-inline="yes-display-inline">shall identify each prescription medication and clinical service covered under such plan for which
			 the amount of the copayment or coinsurance should be reduced or
			 eliminated, with respect to the management of specific chronic clinical
			 conditions (as specified by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>) of MA eligible individuals (as
			 defined in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                <cato:entity-ref value="Social Security Act/s:1851/ss:a/p:3" entity-type="act">section 1851(a)(3) of the Social Security Act</cato:entity-ref> (<cato:entity-ref value="usc/42/1395w–21/a/3" entity-type="uscode">42 U.S.C.
			 1395w–21(a)(3)</cato:entity-ref>)</cato:entity>) enrolled under such plans, for such plan year; and</text>
          </subparagraph>
          <subparagraph id="H2F0A9B8DE84E403FB2D95F860069801E">
            <enum>(B)</enum>
            <text>may, for such plan year, reduce or eliminate copayments, coinsurance, or both for such prescription
			 medication and clinical services so identified with respect to the
			 management of such conditions of such individuals—</text>
            <clause id="H4F89B4DD95724FDA99CEA1EAA946870D">
              <enum>(i)</enum>
              <text>if such reduction or elimination is evidence-based, for the purpose of encouraging such individuals
			 in such plan to use such prescription medications and clinical services
			 (such as preventive care, primary care, specialty visits, diagnostic
			 tests, procedures, and durable medical equipment) with respect to such
			 conditions; and</text>
            </clause>
            <clause id="H47675DD07A19451AA66159685FEABD64">
              <enum>(ii)</enum>
              <text>for the purpose of encouraging such individuals in such plan to use health care providers that such
			 organization has identified with respect to such plan year.</text>
            </clause>
          </subparagraph>
        </paragraph>
        <paragraph id="HE5664C26379D4608A48B86EFE7907158">
          <enum>(3)</enum>
          <header>Prohibition of increases of copayments and coinsurance</header>
          <text display-inline="yes-display-inline">In no case may any Medicare Advantage plan participating in the demonstration program increase, for
			 any plan year for which the plan is so participating, the amount of
			 copayments or coinsurance for any item or service covered under such plan
			 for purposes of discouraging the use of such item or service.</text>
        </paragraph>
      </subsection>
      <subsection id="H65C38DD1344A430A83A8D694AE3E54C6">
        <enum>(d)</enum>
        <header>Report on implementation</header>
        <paragraph id="HAC23F89DEFA244238A160EAC19BD2456">
          <enum>(1)</enum>
          <header>In general</header>
          <text>Not later than 1 year after the date on which the demonstration program under this section begins
			 under subsection (b)(2), the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall submit to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="0001" entity-type="federal-body">Congress</cato:entity-ref> a report
			 on the status of the implementation of the demonstration program.</text>
        </paragraph>
        <paragraph id="H5A81535331D74926955BA6E66BD05565">
          <enum>(2)</enum>
          <header>Elements</header>
          <text>The report required by paragraph (1) shall, with respect to eligible Medicare Advantage plans
			 participating in the demonstration program for the first plan year of such
			 program, include the following:</text>
          <subparagraph id="H45676A5E7CB54150AA7C9BAD45D7709D">
            <enum>(A)</enum>
            <text>A list of each medication and service identified pursuant to subsection (c)(2)(A) for such plan
			 with respect to such plan year.</text>
          </subparagraph>
          <subparagraph id="H59D37F62162B4D36B06FD29438F60E74">
            <enum>(B)</enum>
            <text>For each such medication or service so identified, the amount of the copayment or coinsurance
			 required under such plan with respect to such plan year for such
			 medication or service and the amount of the reduction of such copayment or
			 coinsurance from the previous plan year.</text>
          </subparagraph>
          <subparagraph id="HD944FC4F5BAE4B0E802CDBCAD636AA8B">
            <enum>(C)</enum>
            <text display-inline="yes-display-inline">For each provider identified pursuant to subsection (c)(2)(B)(ii) for such plan with respect to
			 such plan year, a statement of the amount of the copayment or coinsurance
			 required under such plan with respect to such plan year and the amount of
			 the reduction of such copayment or coinsurance from the previous plan
			 year.</text>
          </subparagraph>
        </paragraph>
      </subsection>
      <subsection id="HA128506339BC4CED946D518A7B981002">
        <enum>(e)</enum>
        <header>Review and assessment of utilization of value-Based insurance design methodologies</header>
        <paragraph id="H4BA259779FF14758A3BF4CB96C0E9ECA">
          <enum>(1)</enum>
          <header>In general</header>
          <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall enter into a contract or agreement with an independent, non-biased entity
			 having expertise in value-based insurance design methodologies to review
			 and assess the implementation of the demonstration program under this
			 section. The review and assessment shall include the following:</text>
          <subparagraph id="H42B5812A024B49BA96F737E82F970667">
            <enum>(A)</enum>
            <text>An assessment of the utilization of value-based insurance design methodologies by Medicare
			 Advantage plans participating under such program.</text>
          </subparagraph>
          <subparagraph id="HEFA6992939C045E8A0F611F1156A4EBB">
            <enum>(B)</enum>
            <text>An analysis of whether reducing or eliminating the copayment or coinsurance for each medication and
			 clinical service identified pursuant to subsection (c)(2)(A) resulted in
			 increased adherence to medication regimens, increased service utilization,
			 improvement in quality metrics, better health outcomes, and enhanced
			 beneficiary experience.</text>
          </subparagraph>
          <subparagraph id="HBBDAC6C82FED490EABA0B2FC73B2F488">
            <enum>(C)</enum>
            <text display-inline="yes-display-inline">An analysis of the extent to which costs to Medicare Advantage plans under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/t:XVIII/pt:C">part C of title XVIII of
			 the Social Security Act</cato:entity-ref> participating in the demonstration program is less
			 than costs to Medicare Advantage plans under such part that are not
			 participating in the demonstration program.</text>
          </subparagraph>
          <subparagraph id="H0F1E2B8FE550456299033D62A0E064AD">
            <enum>(D)</enum>
            <text>An analysis of whether reducing or eliminating the copayment or coinsurance for providers
			 identified pursuant to subsection (c)(2)(B)(ii) resulted in improvement in
			 quality metrics, better health outcomes, and enhanced beneficiary
			 experience.</text>
          </subparagraph>
          <subparagraph id="H8D83A4C3FC6748B8BD96BD1215C4C64A">
            <enum>(E)</enum>
            <text display-inline="yes-display-inline">An analysis, for each provider so identified, the extent to which costs to Medicare Advantage plans
			 under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/t:XVIII/pt:C">part C of title XVIII of the Social Security Act</cato:entity-ref> participating in
			 the demonstration program is less than costs to Medicare Advantage plans
			 under such part that are not participating in the demonstration program.</text>
          </subparagraph>
          <subparagraph id="HC1504CF851BD4E588877F7E5B9C02803">
            <enum>(F)</enum>
            <text>Such other matters, as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> considers appropriate.</text>
          </subparagraph>
        </paragraph>
        <paragraph id="HAC192A608AF44590BD2C6B18B54A8FAD">
          <enum>(2)</enum>
          <header>Report</header>
          <text>The contract or agreement entered into under paragraph (1) shall require such entity to submit to
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> a report on the review and assessment conducted by the
			 entity under such paragraph in time for the inclusion of the results of
			 such report in the report required by paragraph (3).</text>
        </paragraph>
        <paragraph id="H1C49C242DD774C93A7EB4D4B48EDA9C9">
          <enum>(3)</enum>
          <header>Report to Congress</header>
          <text>Not later than 3 years after the date on which the demonstration program begins under subsection
			 (b)(2), the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall submit to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="0001" entity-type="federal-body">Congress</cato:entity-ref> a report on the review and
			 assessment of the demonstration program conducted under this subsection.
			 The report shall include the following:</text>
          <subparagraph id="HD1031E3AB4D24977B67AA6101D792892">
            <enum>(A)</enum>
            <text>A description of the results of the review and assessment included in the report submitted pursuant
			 to paragraph (2).</text>
          </subparagraph>
          <subparagraph commented="no" id="HD16475623BED4FCA885441DF285B58F0">
            <enum>(B)</enum>
            <text>Such recommendations as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> considers appropriate for enhancing the utilization of the
			 methodologies applied under the demonstration program to all Medicare
			 Advantage plans under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/t:XVIII/pt:C">part C of title XVIII of the Social Security Act</cato:entity-ref> so
			 as to reduce copayments and coinsurance under such plans paid by Medicare
			 beneficiaries for high-value prescription medications and clinical
			 services for which coverage is provided under such plans and to otherwise
			 improve the quality of health care provided under such plans.</text>
          </subparagraph>
        </paragraph>
      </subsection>
      <subsection commented="no" id="HD03DEC573EB043E3A49456FE68571BC7">
        <enum>(f)</enum>
        <header>Expansion of demonstration program</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall expand the demonstration program, pursuant to notice and comment rulemaking, to
			 implement, on a permanent basis, the components of the demonstration
			 program that are beneficial to Medicare beneficiaries and the Medicare
			 program, unless the report under subsection (d) or (e)(3) contains an
			 evaluation that the demonstration program—</text>
        <paragraph commented="no" id="HEF68EEF30B244E63B85853BA8E3A3846">
          <enum>(1)</enum>
          <text>increases expenditures under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Social Security Act/t:XVIII" entity-type="act">title XVIII</cato:entity-ref> with respect to Medicare beneficiaries participating in
			 the demonstration program; or</text>
        </paragraph>
        <paragraph commented="no" id="H359A8F7F5AE24E2C91C80CE61ACE5994">
          <enum>(2)</enum>
          <text>decreases the quality of health care services furnished to such Medicare beneficiaries
			 participating in the demonstration program.</text>
        </paragraph>
      </subsection>
      <subsection id="H420068931C1C4153B0D299E57B29BF2C">
        <enum>(g)</enum>
        <header>Waiver authority</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> may waive such provisions of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Social Security Act/t:XI" entity-type="act">titles XI</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/t:XVIII">XVIII of the Social Security Act</cato:entity-ref> as may be
			 necessary to carry out the demonstration program under this section.</text>
      </subsection>
      <subsection id="H85C849BADA94431DA79D02D6F74719BB">
        <enum>(h)</enum>
        <header>Implementation funding</header>
        <text>For purposes of carrying out the demonstration program under this section, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall
			 provide for the transfer from the Federal Hospital Insurance Trust Fund
			 under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Social Security Act/s:1817">section 1817 of the Social Security Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395i">
            <cato:entity-ref entity-type="uscode" value="usc/42/1395i">42 U.S.C. 1395i</cato:entity-ref>
          </external-xref>)</cato:entity> and the
			 Federal Supplementary Insurance Trust Fund under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Social Security Act/s:1841">section 1841 of the
			 Social Security Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395t">
            <cato:entity-ref entity-type="uscode" value="usc/42/1395t">42 U.S.C. 1395t</cato:entity-ref>
          </external-xref>)</cato:entity>, including the Medicare Prescription
			 Drug Account in such Trust Fund, in such proportion as determined
			 appropriate by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>, of such sums as may be necessary.</text>
      </subsection>
    </section>
  </legis-body>
</bill>
</doc>